UK trial assessing AZ’ AZD1775 in head and neck cancer

27 Nov 2017
Pharma Times

The trial is being run through the Combinations Alliance, a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network that supports research into drug combinations to bring cancer patients more treatment options that otherwise may not happen.


Click here to read the 'Pharma Times' news article in full